Quisel D. John's Insider Trades & SAST Disclosures
Quisel D. John's most recent trade in Disc Medicine Inc was a trade of 7,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Quisel D. John.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Apr 2025 | 7,000 | 208,420 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share. | 07 Apr 2025 | 7,000 | 161,828 | - | 1.0 | 7,070 | Common Stock |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 54.58 per share. | 18 Feb 2025 | 5,574 | 154,828 | - | 54.6 | 304,229 | Common Stock |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 117,505 | 117,505 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 78,337 | 160,402 | - | 0 | Common Stock | |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.86 per share. | 30 Dec 2024 | 13,012 | 85,077 | - | 9.9 | 128,298 | Common Stock |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2024 | 13,012 | 155,375 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 61.87 per share. | 30 Dec 2024 | 11,112 | 73,965 | - | 61.9 | 687,477 | Common Stock |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2024 | 10,000 | 215,420 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share. | 30 Dec 2024 | 10,000 | 82,065 | - | 1.0 | 10,100 | Common Stock |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 62.41 per share. | 30 Dec 2024 | 1,900 | 72,065 | - | 62.4 | 118,580 | Common Stock |
| Disc Medicine Inc | Quisel D. John | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2024 | 19,820 | 41,830 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | Quisel John D. | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.65 per share. | 23 Dec 2024 | 19,820 | 91,885 | - | 2.7 | 52,523 | Common Stock |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 63.12 per share. | 23 Dec 2024 | 12,194 | 76,277 | - | 63.1 | 769,667 | Common Stock |
| Disc Medicine Inc | D. John Quisel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 63.80 per share. | 23 Dec 2024 | 4,212 | 72,065 | - | 63.8 | 268,733 | Common Stock |
| Disc Medicine Inc | D. Quisel John | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 62.38 per share. | 23 Dec 2024 | 3,414 | 88,471 | - | 62.4 | 212,957 | Common Stock |
| Disc Medicine Inc | Quisel D. John | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2024 | 12,791 | 225,420 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | John Quisel D. | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share. | 16 Dec 2024 | 12,791 | 84,856 | - | 1.0 | 12,919 | Common Stock |
| Disc Medicine Inc | Quisel D. John | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 66.35 per share. | 16 Dec 2024 | 6,305 | 72,565 | - | 66.4 | 418,361 | Common Stock |
| Disc Medicine Inc | Quisel D. John | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 65.58 per share. | 16 Dec 2024 | 5,767 | 78,870 | - | 65.6 | 378,194 | Common Stock |
| Disc Medicine Inc | D. John Quisel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 67.20 per share. | 16 Dec 2024 | 500 | 72,065 | - | 67.2 | 33,599 | Common Stock |
| Disc Medicine Inc | Quisel John D. | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 64.66 per share. | 16 Dec 2024 | 219 | 84,637 | - | 64.7 | 14,160 | Common Stock |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2024 | 3,000 | 238,211 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share. | 08 Jul 2024 | 3,000 | 72,065 | - | 1.0 | 3,030 | Common Stock |
| Gossamer Bio Inc | John D. Quisel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 115,000 | 115,000 | - | - | Non-qualified stock option (Right to Buy) | |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 99,550 | 99,550 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 66,365 | 69,065 | - | 0 | Common Stock | |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share. | 29 Dec 2023 | 2,700 | 2,700 | - | 1.0 | 2,727 | Common Stock |
| Disc Medicine Inc | John Quisel D. | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2023 | 2,700 | 241,211 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2022 | 132,002 | 132,002 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges